Biotech CEO: drug discovery will lag in the AI revolution, not lead it
vaibhavbetter · x · 2026-10-28
Jeb Keiper, who has helped companies pioneering AI for drug discovery, calls the hype BS: AI is a tool worth deploying, but the idea it will unveil new medicines at the pace it upends cinema, gaming or finance is absurd. Drug discovery will lag; healthcare provision, diagnostics and paperwork streamlining will move faster — "biology will continue to eat everything, AI included." Reposter vaibhavbetter agrees AI will mostly accelerate what humans already know; AI doing biology better than humans remains speculation.
More from AGI Musings
- AI-written emails are quietly hurting workplace optics and relationships, dev warns — tekbog · 2026-10-28
- Janus-era alignment debate: we lucked into one Good AI, then went back to minting traumatized bureaucrats — repligate · 2026-10-28
- AI Outliving Its Creators Could Turn Temporary Ownership Into Lasting Institutions — PierceLilholt · 2026-10-28
- Yacine MTB: AI automation of software engineering is likely more than a year out — yacineMTB · 2026-10-28
- tszzl: Yudkowsky's AI first-strike take has entered the Overton window after 2023 backlash — tszzl · 2026-10-28
- Percy Liang: experts rate 1/3 of AI-proposed research questions genuinely interesting — StanfordAILab · 2026-10-28